IFX_Workshops_Tutorials

Pharos: Illuminating the Druggable Genome

Table of Contents

  1. Introduction to Pharos
  2. Tools for your toolbox
  3. Scavenger Hunt
  4. Contact Us

Introduction to Pharos

Pharos is the flagship web interface for the Illuminating Druggable Genome (IDG) Consortium, an NIH Common Fund project. Pharos integrates cutting-edge informatics tools and serves as your portal to access valuable insights and resources about understudied protein targets.

Pharos is designed to streamline your research and data analysis tasks. It offers a wide range of features to help you explore, visualize, and analyze your datasets efficiently.

This workshop will help you explore, analyze, and download data via the web platform, as well as programmatically through the API.

Tools for your toolbox

1. Finding specific targets, diseases, or ligands

2. Reviewing primary documentation

3. List pages

Scavenger Hunt

answers

  1. Finding primary documentation
    1. What is the MONDO description for “asthma?”
    2. How many Tclin targets have associations to this disease?
    3. Which sub-class of “asthma” has the most target associations?
  2. Finding ligands for a target
    1. Find the details page for target MAPK11
    2. How many active compounds are there for that target?
    3. How many have a potency above greater than or equal to 8? (i.e. 1e-8 M = 10nM)
    4. How many are selective for that target? (how many have only one documented target activity)
  3. Illuminating a dark target
    1. What TDL is RAD21L1?
    2. How many direct disease associations does it have?
    3. How many interacting targets does it have?
    4. What is the most common disease associated with RAD21L1?
    5. What is the top two diseases that are enriched in the population of interacting targets?
    6. What targets have sequence similarity to Gene X? (return to target details page - find the sequence)
  4. Disease Lists
    1. How many diseases are in Pharos
    2. How many are annotated to be Rare Diseases, based on GARD?
    3. Of those rare diseases, how many have an associated target that has an approved drug?
  5. Investigating a new chemical compound
    1. Example smiles - CC1CC(O)(CCN1CCCC(=O)C1=CC=C(F)C=C1)C1=CC=C(Cl)C=C1
    2. How many ligands in Pharos have some structural similarity?
    3. How many ligands hav 0.8 or greater similarity
    4. What target has activity to the most ligands in that list?
  6. Using UpSet Plots
    1. How many targets were on the Original IDG List?
    2. How many targets are on the current IDG List (2022 list)?
    3. How many were on the original list, but are no longer on the current IDG List?

Contact Us

We’re here to help! If you have any questions, feedback, or need assistance, please feel free to reach out to our team at pharos@mail.nih.gov.